Page 103 - Read Online

Page 10 of 10 Berghen et al. J Cancer Metastasis Treat 2021;7:58 https://dx.doi.org/10.20517/2394-4722.2021.123

44. Malouff TD, Mahajan A, Krishnan S, Beltran C, Seneviratne DS, Trifiletti DM. Carbon Ion Therapy: a modern review of an emerging
technology. Front Oncol 2020;10:82. DOI PubMed PMC
45. Gergelis KR, Jethwa KR, Tryggestad EJ, Ashman JB, Haddock MG, Hallemeier CL. Proton beam radiotherapy for esophagus cancer:
state of the art. J Thorac Dis 2020;12:7002-10. DOI PubMed PMC
46. Fukumitsu N, Ishikawa H, Arimura T, et al. Proton therapy for primary renal cell carcinoma: the first nationwide retrospective study in
Japan. In Vivo 2020;34:2883-9. DOI PubMed PMC
47. Baydoun A, Vapiwala N, Ponsky LE, et al. Comparative analysis for renal stereotactic body radiotherapy using Cyberknife, VMAT
and proton therapy based treatment planning. J Appl Clin Med Phys 2018;19:125-30. DOI PubMed PMC
48. Thompson A, Ding X, Abbott V, et al. Proton stereotactic body radiotherapy as a nephron-sparing approach for patients with localized
renal cell carcinoma: a dosimetric analysis. Int J Radiat Oncol 2019;105:E713. DOI
49. Nomiya T, Tsuji H, Hirasawa N, et al. Carbon ion radiation therapy for primary renal cell carcinoma: initial clinical experience. Int J
Radiat Oncol Biol Phys 2008;72:828-33. DOI PubMed
50. Kasuya G, Tsuji H, Nomiya T, et al; Working Group for Genitourinary Tumors. Updated long-term outcomes after carbon-ion
radiotherapy for primary renal cell carcinoma. Cancer Sci 2018;109:2873-80. DOI PubMed PMC
51. Kasuya G, Tsuji H, Nomiya T, et al; Working Group for Genitourinary Tumors. Prospective clinical trial of 12-fraction carbon-ion
radiotherapy for primary renal cell carcinoma. Oncotarget 2019;10:76-81. DOI PubMed PMC
52. Nakao HT. A case of lung and lymphnode metastasis treated with carbon ion radiotherapy after radical nephrectomy for renal cell
carcinoma. Hinyokika Kiyo 2008;54:345-7. DOI
53. Rief H, Chaudhri N, Tonndorf-Martini E, et al. Intensity-modulated radiotherapy versus proton radiotherapy versus carbon ion
radiotherapy for spinal bone metastases: a treatment planning study. J Appl Clin Med Phys 2015;16:186-194. DOI PubMed PMC
54. Macewan I, Chou B, Mifflin R, Wroe A, Bush D. Passively scattered proton stereotactic body radiation therapy for spine metastasis: a
dosimetric analysis. Int J Radiat Oncol 2016;96:E675-6. DOI
55. Loeffler JS, Durante M. Charged particle therapy-optimization, challenges and future directions. Nat Rev Clin Oncol 2013;10:411-24.
DOI PubMed
56. Ruysscher D, Sterpin E, Haustermans K, Depuydt T. Tumour movement in proton therapy: solutions and remaining questions: a
review. Cancers (Basel) 2015;7:1143-53. DOI PubMed PMC
57. Bert C, Durante M. Motion in radiotherapy: particle therapy. Phys Med Biol 2011;56:R113-44. DOI
58. Buti G, Souris K, Montero AMB, Lee JA, Sterpin E. Towards fast and robust 4D optimization for moving tumors with scanned proton
therapy. Med Phys 2019;46:5434-43. DOI PubMed
59. Verma V, Mishra MV, Mehta MP. A systematic review of the cost and cost-effectiveness studies of proton radiotherapy. Cancer
2016;122:1483-501. DOI PubMed